Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for inflammatory disease and cancer.
Through our unique understanding of fibroblast immunology, we are advancing a pipeline of first-in-class antibody programs and targets for new treatments.
Backed by committed leading global investors, world-class founders and a highly experienced leadership team, Mestag offers an exciting, diverse and balanced place to work, with competitive benefits, generous vacation time and the room to grow and develop your career.
Company Details
- Employees
- 55
- Founded
- -
- Address
- London, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://mestagtherapeutics.com/
- HQ
- London
Mestag Therapeutics Questions
Mestag Therapeutics's website is https://mestagtherapeutics.com/
Mestag Therapeutics's LinkedIn profile is https://www.linkedin.com/company/mestag-therapeutics
Mestag Therapeutics has
55 employees.
View email and phone details for 55
employees at Mestag Therapeutics.
Mestag Therapeutics's industry is
Biotechnology Research
Mestag Therapeutics's top competitors are
Alchemab Therapeutics Ltd,
Charm Therapeutics,
Quell Therapeutics,
Laverock Therapeutics,
Aviadobio,
Maxion Therapeutics,
Autolus Therapeutics,
Bicycle Therapeutics,
Amphista Therapeutics Limited,
Bit.bio.
Mestag Therapeutics's categories are Biotechnology Research
Mestag Therapeutics's founding year is 2020
